Trials / Completed
CompletedNCT01497990
Pharmacokinetics Ertapenem Burns
Pharmacokinetics of Ertapenem When Used in Empiric Treatment in Burn Patients. Prospective Open Label Study.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Nantes University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study will examine the pharmacokinetics of ertapenem in ventilated badly (\> 30% SCT) burn patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ertapenem | The patient received two injections of ertapenem, at a dose of 1g.j-1 by intravenous injection of 30 minutes, separated by 24 h. |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2011-09-01
- Completion
- 2011-09-01
- First posted
- 2011-12-23
- Last updated
- 2012-11-05
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01497990. Inclusion in this directory is not an endorsement.